TDP-43 interacts with pathological τ protein in Alzheimer’s disease

[1]  I. Mackenzie,et al.  Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes , 2020, Acta Neuropathologica.

[2]  R. Vandenberghe,et al.  Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes , 2020, Acta Neuropathologica Communications.

[3]  C. Jack,et al.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.

[4]  C. Jack,et al.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains , 2019, Acta Neuropathologica.

[5]  Masato Hasegawa,et al.  Comorbid pathologies of neurodegenerative diseases Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases , 2018 .

[6]  T. Takeda,et al.  Possible concurrence of TDP‐43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration , 2018, Neuropathology : official journal of the Japanese Society of Neuropathology.

[7]  Jennifer L. Whitwell,et al.  Updated TDP-43 in Alzheimer’s disease staging scheme , 2016, Acta Neuropathologica.

[8]  Jeffrey A. Golden,et al.  Hereditary spastic paraplegia‐linked REEP1 modulates endoplasmic reticulum/mitochondria contacts , 2015, Annals of neurology.

[9]  L. Petrucelli,et al.  TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features , 2015, Annals of neurology.

[10]  C. Jack,et al.  TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.

[11]  C. Lemere,et al.  Regional distribution of TDP‐43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  H. Akiyama,et al.  Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies , 2009, Acta Neuropathologica.

[13]  C. Jack,et al.  Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype , 2008, Neurology.

[14]  H. Arai,et al.  Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.

[15]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.